November 13, 2023
Startup PBMs See Growth in Price Transparency A series of startup PBMs are seeing some success signing up health plans by riding the price transparency train. They have even set up their own trade group to differentiate themselves from traditional PBM lobbying efforts. An interesting development, but one that will take time to break the dominance of the three giants, which control about 80% of all the business. (may require subscription) #medicareadvantage #commercial #medicaid #pbms #pricetransparency Link to Article Health Affairs Forefront Blog on FDA Process I am a notable critic of the FDA. I see it as a revolving door agency (FDA to brand PhRMA and back again) and dominated by pressure from the drug industry to approve drugs that are not often ready for launch. In fairness to the FDA, here is a good article on the process and challenges FDA has, including from advocates. (may require subscription)
